Pressure Products offers a complete line of haemostatic peel-
The industry standard SafeSheath combines introducer with a hemostatic valve to prevent
back-
CathRx is a specialist Australian medical device company focusing on the development and commercialisation of a range of innovative cardiac catheters for use in the diagnosis and treatment of electrical problems of the heart known as cardiac arrhythmias.
The Company is listed on the Australian Securities Exchange where it is traded under the symbol CXD. Its head office, laboratory and manufacturing facilities are based at Homebush Bay in Sydney.
The Company prides itself on innovative design and technology to provide catheters with significant advantages for the cardiac clinicians and patients.
Cross the atrial septum with Confidence
The SafeSept™ Transseptal Guidewire, is the first significant advance in left atrial access since the Brockenbrough needle.
SafeSept is a 0.014 inch diameter, 120 cm long nitinol guidewire specifically designed for transseptal puncture. After the transseptal dilator has “tented” the fossa ovalis, effortless advancement of the SafeSept tip perforates the membranous fossa. Unsupported by the needle and dilator, the tip of the wire assumes a ‘J’ shape, rendering it incapable of further tissue penetration hence removing the risk of perforation.
A radiopaque coil on the shaft allows for visualization of the wire within the left atrium and proximal white printed markers help approximate the location of the SafeSept tip in relation to the tip of the needle. The transseptal needle, dilator and sheath are then advanced “over the wire” into the left atrium with virtually no possibility of aortic or pericardial perforation.
The SafeSept Transseptal Guidewire is part of a complete line of implantable device therapy products and accessories from Pressure Products.
–-